Infectious disease
Influenza control Peptide Pool (>95% HPLC)
Product number:
LB01715
€ 215.00 *
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
>95% HPLC-MS
Caution:
For research use only. Not for use in humans.
1
Description
This pool consists of 17 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from influenza:
| Sequence | Corresponding Catalog Peptide | Allel | |
|---|---|---|---|
| 1 | ILGFVFTLTV | Influenza A M1 59-68 Peptide | HLA-A*02:01 |
| 2 | ILRGSVAHK | Influenza A (PR8) NP 265-274 Peptide | HLA-A*03:01 |
| 3 | KSMREEYRK | Influenza A MP2 70-78 Peptide | HLA-A*11:01 |
| 4 | RMVLASTTAK | Influenza A M1 178-187 Peptide | HLA-A*11:01 |
| 5 | QPEWFRNVL | Influenza A PB1 329-337 Peptide | HLA-A*07:02 |
| 6 | SPIVPSFDM | Influenza A NP 473-481 Peptide | HLA-A*07:02 |
| 7 | CTELKLSDY | Influenza A NP 44-52 Peptide | HLA-A*01:01 |
| 8 | VSDGGPNLY | Influenza A PB1 591-599 Peptide | HLA-A*01:01 |
| 9 | FMYSDFHFI | Influenza Virus PA 46-54 Peptide | HLA-A*02:01 |
| 10 | GILGFVFTL | Influenza A M1 58-66 Peptide | HLA-A*02:01 |
| 11 | RVLSFIKGTK | Influenza Virus NP 342-351 Peptide | HLA-A*03:01 HLA-A*31:01 HLA-A*33:01 |
| 12 | SIIPSGPLK | Influenza A M1 13-21 Peptide | HLA-A*11:01 HLA-A*03:01 HLA-A*31:01 HLA-A*68:01 |
| 13 | KTGGPIYKR | Influenza Virus NP 91-99 Peptide | HLA-A*68:01 |
| 14 | ASCMGLIY | Influenza A M1 125-132 Peptide | HLA-B27 HLA-B35 |
| 15 | SRYWAIRTR | Influenza A NP 383-391 Peptide | HLA-A*27:05 |
| 16 | LPFDKTTVM | Influenza NP 418-426 Peptide | HLA-B*07:02 |
| 17 | ELRSRYWAI | Influenza Virus NP 380-388 Peptide | HLA-B8 |
One unit allows the stimulation of 2,5 x 108 cells.
TechData
| Delivery: | 1-3 days |
| Counterion: | TFA |
| No. Peptides: | 17 peptides |
| Amount/Aliquote: | 15 nmol (approx. 25µg)/peptide for stimulation of 2,5 x 108 cells |
| Solubility: | Dissolve in a minimum amount of pure DMSO (40µl) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. |
| Species: | Influenza A virus |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Infectious disease, Control |
| Purity: | >95% HPLC-MS |